Keck School Faculty

Jennifer Ho
Jennifer Ho
Assistant Professor Of Clinical Radiation Oncology
Radiation Oncology
1500 San Pablo Street Health Sciences Campus Los Angeles
Jennifer Ho, MD, is an Assistant Professor of Clinical in the Department of Radiation Oncology at the Keck School of Medicine of USC . She will serve as the primary radiation oncologist at Arcadia Medical Office Building when it opens in the Fall of 2019. She will be working closely with community providers to increase access, and provide Keck Medicine quality care in the community that mirrors standards set at Keck Medical Center of USC. Until that time Dr. Ho will treat patients at Norris Cancer Hospital and Keck Hospital.

Dr. Ho graduated with honors from Duke University with a Bachelor of Science in Psychology. She received her medical degree from Duke University School of Medicine with a Dean’s Merit Full Tuition Scholarship. During medical school, she spent one year performing clinical and translational research at the National Cancer Institute, as a fellow in the NIH Clinical Research Training Program. She completed her internship in Internal Medicine at the University of North Carolina Hospital. She subsequently completed her radiation oncology residency training at MD Anderson Cancer Center.

Dr. Ho has published numerous papers and given presentations on research topics including irradiation of lung and head and neck cancers, stereotactic radiosurgery, stereotactic spine radiation, and MRI as a prognostic indicator. She has expertise in advanced radiation techniques, including stereotactic body radiation therapy (SBRT), and intensity modulated radiation therapy (IMRT), and is interested in studying the role of these techniques to effectively treat cancer while minimizing side effects. She is dedicated to providing excellent, patient-centered care, and is passionate about being an advocate for her patients and their families.

Languages Spoken: English, and Mandarin Chinese

Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer Radiother Oncol. 2019 Jun; 135:58-64. . View in PubMed

Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer Radiother Oncol. 2019 Mar 11; 135:58-64. . View in PubMed

Stereotactic radiosurgery for trigeminal pain secondary to recurrent malignant skull base tumors J Neurosurg. 2018 Apr 27; 130(3):812-821. . View in PubMed

Stereotactic radiosurgery for trigeminal pain secondary to recurrent malignant skull base tumors J Neurosurg. 2018 Apr 01; 1-10. . View in PubMed

Reirradiation of head and neck cancer using modern highly conformal techniques Head Neck. 2018 09; 40(9):2078-2093. . View in PubMed

Reirradiation of thoracic cancers with intensity modulated proton therapy Pract Radiat Oncol. 2018 Jan - Feb; 8(1):58-65. . View in PubMed

Reirradiation of Skull Base Tumors With Advanced Highly Conformal Techniques Curr Oncol Rep. 2017 Oct 28; 19(12):82. . View in PubMed

Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma<sup/> Leuk Lymphoma. 2017 12; 58(12):2833-2844. . View in PubMed

Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):546-553. . View in PubMed

The use of spine stereotactic radiosurgery for oligometastatic disease J Neurosurg Spine. 2016 Aug; 25(2):239-47. . View in PubMed

Gamma Knife Stereotactic Radiosurgery for Brain Metastases Using Only 3 Pins Neurosurgery. 2016 Jun; 78(6):877-82. . View in PubMed

Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction Circulation. 2016 Feb 02; 133(5):484-92. . View in PubMed

Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes Circ Heart Fail. 2016 06; 9(6). . View in PubMed

Serial galectin-3 and future cardiovascular disease in the general population Heart. 2016 07 15; 102(14):1134-41. . View in PubMed

Racial Differences in Electrocardiographic Characteristics and Prognostic Significance in Whites Versus Asians J Am Heart Assoc. 2016 03 25; 5(3):e002956. . View in PubMed

Management of nodal recurrences of endometrial cancer with IMRT Gynecol Oncol. 2015 Oct; 139(1):40-6. . View in PubMed

Distinct metabolomic signatures are associated with longevity in humans Nat Commun. 2015 Apr 13; 6:6791. . View in PubMed

Stromal cell-derived factor 1 as a biomarker of heart failure and mortality risk Arterioscler Thromb Vasc Biol. 2014 Sep; 34(9):2100-5. . View in PubMed

Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology. 2013 Jul; 268(1):144-52.. View in PubMed

Role of radiotherapy in adrenocortical carcinoma Cancer J. 2013 Jul-Aug; 19(4):288-94. . View in PubMed

Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction Circ Heart Fail. 2013 Mar; 6(2):279-86. . View in PubMed

Chemoirradiation for glioblastoma multiforme: the national cancer institute experience PLoS One. 2013; 8(8):e70745. . View in PubMed

Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study) Am J Cardiol. 2012 Jun 15; 109(12):1761-6. . View in PubMed

Multifactorial regulation of E-cadherin expression: an integrative study Mol Cancer Ther. 2010 Jan; 9(1):1-16. . View in PubMed

Powered by SC CTSI
Go to Top